These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25843191)

  • 21. [Research advances in diagnosis of non-alcoholic fatty liver disease].
    Wang JH; Yu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):115-118. PubMed ID: 28297797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of imaging in nonalcoholic fatty liver disease.
    Li Q; Dhyani M; Grajo JR; Sirlin C; Samir AE
    World J Hepatol; 2018 Aug; 10(8):530-542. PubMed ID: 30190781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Liver Biopsy Necessary in Patients With Nonalcoholic Fatty Liver Disease?
    Gavril RS; Mihalache L; Arhire L; Grosu C; Gherasim A; Nita O; Oprescu AC; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):503-7. PubMed ID: 30044567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of fibrosis markers.
    Patel K; Shackel NA
    Curr Opin Gastroenterol; 2014 May; 30(3):253-9. PubMed ID: 24671009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.
    Marzuillo P; Grandone A; Perrone L; Miraglia Del Giudice E
    World J Gastroenterol; 2015 Jun; 21(21):6444-50. PubMed ID: 26074683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Kogachi S; Noureddin M
    Clin Ther; 2021 Mar; 43(3):455-472. PubMed ID: 33581876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.
    Tomic D; Kemp WW; Roberts SK
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1103-1115. PubMed ID: 30113367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
    Oh H; Jun DW; Saeed WK; Nguyen MH
    Clin Mol Hepatol; 2016 Sep; 22(3):327-335. PubMed ID: 27729634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
    PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive methods to diagnose NAFLD.
    Sureka B; Bansal K; Arora A
    Saudi J Gastroenterol; 2015; 21(4):259. PubMed ID: 26228371
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.
    Festi D; Schiumerini R; Marasco G; Scaioli E; Pasqui F; Colecchia A
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1039-53. PubMed ID: 25993881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
    Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
    J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.
    El-Koofy N; El-Karaksy H; El-Akel W; Helmy H; Anwar G; El-Sayed R; El-Hennawy A
    Eur J Radiol; 2012 Nov; 81(11):3120-3. PubMed ID: 22817846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods.
    Lăpădat AM; Jianu IR; Ungureanu BS; Florescu LM; Gheonea DI; Sovaila S; Gheonea IA
    J Med Life; 2017; 10(1):19-26. PubMed ID: 28255371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease - current status and future directions.
    Demir M; Lang S; Steffen HM
    J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.